SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-011034
Filing Date
2023-04-10
Accepted
2023-04-10 16:05:21
Documents
1
Period of Report
2023-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3370
  Complete submission text file 0000899243-23-011034.txt   4749
Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address
Young Richard A (Reporting) CIK: 0001490283 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40657 | Film No.: 23811176

Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)